Home » Topics » Regulatory

Regulatory
RSS

Cipralex approved in Sweden; European mutual recognition procedure initiated

Dec. 11, 2001

FDA approval for intravenous formulation of Avelox

Dec. 10, 2001

Antizol receives additional approval in Canada for methanol poisoning

Dec. 10, 2001

Tetracycline antibiotic finds new use as neuroprotective agent 30 years later

Dec. 7, 2001

First approval obtained for new BPH therapeutic from GSK

Dec. 4, 2001

Teveten HCT receives marketing approval in U.S.

Dec. 4, 2001

FDA clears injectable antibiotic Invanz

Dec. 3, 2001

FDA marketing approval granted for improved form of Ritalin for ADHD

Dec. 3, 2001

Canadian approval for Fludara as NHL treatment

Dec. 3, 2001

Zenapax enters phase II trial in patients with chronic asthma

Dec. 3, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...